<DOC>
	<DOCNO>NCT00433199</DOCNO>
	<brief_summary>Demonstrate efficacy safety Testosterone Gel 1.62 % treatment hypogonadal men</brief_summary>
	<brief_title>Testosterone Treatment Hypogonadal Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Low T males 18 80 year age Normal T level Elevated Prostatic Specific Antigen ( PSA )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Testosterone Deficiency</keyword>
</DOC>